Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Neoplasm Metastasis 2Sarcoma, Synovial 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rectal Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Myelodysplastic Syndromes 1Melanoma 1Liposarcoma, Myxoid 1Graft vs Host Disease 1Colonic Neoplasms 1Carcinoma, Merkel Cell 1

Interventions

Cyclophosphamide 39fludarabine phosphate 37Azacitidine 33fludarabine 25Whole-Body Irradiation 22Busulfan 22Tacrolimus 21Antilymphocyte Serum 21Mycophenolic Acid 19Filgrastim 18Methotrexate 16Melphalan 15venetoclax 13Peripheral Blood Stem Cell Transplantation 13Granulocyte Colony-Stimulating Factor 13Cytarabine 13thymoglobulin 12Cyclosporine 12Thiotepa 9Cord Blood Stem Cell Transplantation 9Alemtuzumab 8Rituximab 7Radiotherapy 7Methylprednisolone 7Decitabine 7Clofarabine 7Lenalidomide 6Stem Cell Transplantation 5Sirolimus 5Nivolumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Myelodysplastic Syndromes × Interferon-gamma × Clear all
NCT04328714 2026-02-13

Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease

Emory University

Phase 1 Terminated
4 enrolled
Myeloid

Graft vs Host Disease, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡